Curocell Statistics

Total Valuation

Curocell has a market cap or net worth of KRW 432.57 billion. The enterprise value is 458.87 billion.

Market Cap	432.57B
Enterprise Value	458.87B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Curocell has 14.32 million shares outstanding.

Current Share Class	14.32M
Shares Outstanding	14.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	33.65%
Owned by Institutions (%)	10.55%
Float	9.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	19.00
P/TBV Ratio	22.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.94
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.02

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 2.77.

Current Ratio	1.02
Quick Ratio	0.99
Debt / Equity	2.77
Debt / EBITDA	n/a
Debt / FCF	-2.34
Interest Coverage	-14.59

Financial Efficiency

Return on equity (ROE) is -86.66% and return on invested capital (ROIC) is -22.53%.

Return on Equity (ROE)	-86.66%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-22.53%
Return on Capital Employed (ROCE)	-53.42%
Revenue Per Employee	n/a
Profits Per Employee	-260.82M
Employee Count	136
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Curocell has paid 1.10 million in taxes.

Income Tax	1.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.42% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+16.42%
50-Day Moving Average	28,956.00
200-Day Moving Average	28,782.40
Relative Strength Index (RSI)	55.24
Average Volume (20 Days)	63,741

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-11.17M
Operating Income	-33.86B
Pretax Income	-35.47B
Net Income	-35.47B
EBITDA	-27.56B
EBIT	-33.86B
Earnings Per Share (EPS)	-2,511.78

Full Income Statement

Balance Sheet

The company has 36.82 billion in cash and 63.12 billion in debt, giving a net cash position of -26.30 billion or -1,835.90 per share.

Cash & Cash Equivalents	36.82B
Total Debt	63.12B
Net Cash	-26.30B
Net Cash Per Share	-1,835.90
Equity (Book Value)	22.76B
Book Value Per Share	1,602.98
Working Capital	685.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -26.81 billion and capital expenditures -155.11 million, giving a free cash flow of -26.97 billion.

Operating Cash Flow	-26.81B
Capital Expenditures	-155.11M
Free Cash Flow	-26.97B
FCF Per Share	-1,882.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Curocell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.20%
FCF Yield	-6.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1